Only a small minority of the numerous patients who visit emergency departments (Eds) with chest pain (8-10 million per year in the USA) have acute myocardial infarction (MI) or another life-threatening disorder. 1 However, failing to detect a serious condition can entail grave clinical sequelae and/or major liability. Thus, the dilemma of low risk but high stakes in this patient population continues to drive the search for innovative strategies to afford rapid identification of patients requiring admission and safe, early discharge in the large majority with a benign problem.
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Approaches to this challenge have undergone continuous evolution over the past several decades. Historical 'rule out MI' procedures consuming days of testing have given way to contemporary accelerated diagnostic protocols (ADPs) that have reduced the evaluation to hours. ADPs are based on initial recognition of low risk reflected by clinical stability, normal electrocardiogram (ECG), and negative cardiac injury markers, usually followed by a predischarge cardiac test (PDT) to endorse suitability for early discharge. [1] [2] [3] PDTs vary from exercise ECG to stress imaging or computed tomography coronary angiography (CTCA), depending on institutional resources, expertise and physician preference. Negative results allow discharge with outpatient follow-up while abnormal findings mandate admission. For more than two decades, this strategy has averted unnecessary admissions, reduced length of stay (LOS) and resulted in safe outcomes. 1, 3, 4 ADPs have been associated with a greater than 99% negative predictive value for adverse cardiac events at 30 days or longer. 1 However, despite these commendable results, the necessity of routine predischarge cardiac testing to conclude a negative evaluation convincingly in low-risk patients has been challenged on grounds of rationale, resource utilization, and cost. [5] [6] [7] The report by Ljung et al. 8 in this issue of the European Journal of Cardiology: Acute Cardiovascular Care reflects the superfluous role of routine PDT, in their case by ECG ergometry, following the exclusion of MI in low-risk chest pain patients. Their study is robust. It comprised 951 consecutive low-risk chest pain patients enrolled over 1 year, of whom 45% were women, and all patients were tested by exercise ECG and high-sensitivity cardiac troponin (hs-cTn) prior to discharge to exclude MI. The 1-year post-hospital follow-up is longer than in most such investigations, and a matched control group was included to compare outcomes with the patients. The study cohort may be considered somewhat higher risk than typical for this type of patient population: the average age was 62 years, risk factors were ample, a quarter had a history of ischaemic heart disease and another 5% had a previous stroke or peripheral artery disease. The distribution of positive, negative and non-conclusive exercise ECGs (<10%, >60%, >25%, respectively) differed from other studies in this setting only in the relatively high rate of nonconclusive tests. 1, 3, 4, 7 Total mortality in the patients was 0.9% at 1 year and MIs were 1.1%. Notably, there were no differences in these low rates of mortality and MIs between patients with positive or negative exercise tests at 3 months or 1 year and between patients and controls. The authors concluded that their findings suggest that patients of the type they evaluated can be discharged without predischarge exercise ECG testing. In eschewing PDT, it is appreciated that Ljung et al. applied some of the most definitive contemporary methods in combination to identify appropriate patients for early discharge: (a) exercise ECG ergometry and (b) hs-cTn. Each of these methods separately is associated with a negative predictive value greater than 99% for acute MI, 1, 9, 10 and their combined use would be expected to further enhance the reliability of this dual test sequence in excluding MI.
The omission of predischarge testing is not a novel concept. The availability of hs-cTn in Europe and Asia has afforded a greater than 99% negative predictive value for MI without PDT in large cohorts of low-risk patients presenting with chest pain. 9, 10 In this regard, hs-cTn is not yet available for clinical application in the USA. Yet, the most common strategy we employ at our institution in low-risk chest pain patients is conventional cardiac troponin without PDT, which also yields a negative predictive value of over 99% for major adverse cardiac events at 30 days to 6 months. The report of Ljung et al. is one of a growing number of studies suggesting that routine PDT of low-risk patients presenting to the ED with chest pain is neither necessary nor cost-effective. Prasad et al. 5 have persuasively reviewed the evidence against this practice in terms of increased costs, the absence of improved clinical outcomes and obsolete rationale. Indeed, in the current state of our knowledge, it is reasonable to call a halt to routine predischarge testing in favor of physician discretion in the selection of patients for PDT.
Ljung et al. acknowledge the limitations of their study. Their assessment is retrospective, with the associated restrictions of that method, and represents work from a single centre, possibly curbing generalisability. In addition, it is unclear whether myocardial revascularisation was actually beneficial in the small number of patients receiving this therapy, as pointed out by Gibbons in his commentary on CTCA in the ED. 11 On the other hand, omission of a procedure that is unnecessary in many patients confers the advantage of decreased LOS, a key factor in cost-effective patient management. Rapid patient evaluation in chest pain units has contributed to this goal. 3 In this regard, CTCA also reduces LOS compared with usual care of low-risk chest pain patients. In one report, LOS was lowered from 31 hours with standard care to 23 hours with CTCA. 12 By contrast, we have reported LOS as low as 10 hours in patients receiving PDT and 6 hours in non-tested patients. 3, 13 Even shorter LOS has been reported with a 2-hour ADP using hs-cTn and no functional cardiac testing. 9 The authors raise several points meriting further consideration. They note that ECG testing is a reliable method to detect ischaemic heart disease. The sensitivity of the exercise ECG to detect obstructive coronary artery disease depends on a number of factors but is generally considered to be no more than 65-70%. We value maximum exercise testing in assessing low-risk chest pain patients not for its reliability in detecting coronary disease but because it is highly unlikely that a patient experiencing acute coronary syndrome would have a negative maximum exercise ECG with no symptoms of ischaemia. We agree with Ljung et al. that there is no scientific basis for considering the traditional goal of over 80% or 85% or greater age-predicted maximum heart rate as a reliable target heart rate for inducing myocardial ischaemia. In fact, in one of our early studies, we reported that a negative exercise test at 75% or greater of age-predicted maximum heart rate was associated with a very low prognostic risk in chest pain unit patients. 4 The basis of these findings is that our purpose of exercise testing in the chest pain unit is not to detect coronary disease but to exclude acute coronary syndrome and allow safe discharge for further outpatient evaluation. Finally, we agree with Ljung and coworkers that patients taking rate-limiting anti-anginal therapy pose a challenge in terms of the reliability of exercise testing. However, we have examined this apprehension and found that adequate exercise-induced tachycardia is achieved by a sizeable enough proportion of patients not to preclude this test when appropriate because of potentially rate-limiting therapy. 14 Ljung and co-authors have furthered our common goal of enhancing the evaluation of low-risk patients presenting to the ED with chest pain. More selective testing and simpler assessment promises increased benefits of shorter LOS and improved resource utilisation without limiting patient safety.
